Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma

[1]  K. Miller,et al.  Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome. , 2007, Cancer letters.

[2]  E. Dahl,et al.  Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma , 2007, Oncogene.

[3]  Mala Sinha,et al.  Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma , 2007, Clinical Cancer Research.

[4]  Shohachi Suzuki,et al.  Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma. , 2007, The Journal of surgical research.

[5]  A. Batistatou,et al.  The role of intercellular adhesion molecule-1 in head and neck cancer. , 2006, Experimental oncology.

[6]  J. Köllermann,et al.  Promoter Hypermethylation Profile of Kidney Cancer with New Proapoptotic p53 Target Genes and Clinical Implications , 2006, Clinical Cancer Research.

[7]  G. Bepler,et al.  Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase. , 2006, Cancer research.

[8]  R. Uzzo,et al.  Identification of novel target genes by an epigenetic reactivation screen of renal cancer. , 2006, Cancer research.

[9]  H. Asamura,et al.  Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma , 2006, Cancer.

[10]  M. Toyota,et al.  Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma , 2006, Oncogene.

[11]  C. Rogers,et al.  Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  D. Gutmann,et al.  Promoter hypermethylation of the potential tumor suppressor DAL‐1/4.1B gene in renal clear cell carcinoma , 2006, International journal of cancer.

[13]  E. Liu,et al.  THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma , 2005, Oncogene.

[14]  B. Teh,et al.  Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. , 2005, Cancer research.

[15]  B. Trock,et al.  Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy , 2005, Clinical Cancer Research.

[16]  Joachim Diebold,et al.  Functional epigenomics identifies genes frequently silenced in prostate cancer. , 2005, Cancer research.

[17]  R. Uzzo,et al.  Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. , 2003, Cancer research.

[18]  L. Hesson,et al.  Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma , 2003, Oncogene.

[19]  S. Akira,et al.  Integral role of Noxa in p53-mediated apoptotic response. , 2003, Genes & development.

[20]  T. Kita,et al.  Cutting Edge: SR-PSOX/CXC Chemokine Ligand 16 Mediates Bacterial Phagocytosis by APCs Through its Chemokine Domain1 , 2003, The Journal of Immunology.

[21]  J. Cameron,et al.  Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. , 2003, Cancer research.

[22]  F. Sato,et al.  Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. , 2002, Cancer cell.

[23]  J. Minna,et al.  Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers , 2002, Oncogene.

[24]  G. Pfeifer,et al.  Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas , 2001, International journal of cancer.

[25]  H. Moch,et al.  Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. , 2001, Cancer research.

[26]  A. Protopopov,et al.  The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Soler,et al.  Expression Cloning of the STRL33/BONZO/TYMSTR Ligand Reveals Elements of CC, CXC, and CX3C Chemokines , 2001, The Journal of Immunology.

[28]  T. Kita,et al.  Molecular Cloning of a Novel Scavenger Receptor for Oxidized Low Density Lipoprotein, SR-PSOX, on Macrophages* , 2000, The Journal of Biological Chemistry.

[29]  Sharon Engel,et al.  A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.

[30]  D. Jensen,et al.  BAP1, a Candidate Tumor Suppressor Protein That Interacts with BRCA1 , 1999, Annals of the New York Academy of Sciences.

[31]  G. Milo,et al.  Keratin 19 Downregulation by Oral Squamous Cell Carcinoma Lines Increases Invasive Potential , 1999, Journal of dental research.

[32]  B. Delahunt,et al.  The Heidelberg classification of renal cell tumours , 1997, The Journal of pathology.

[33]  S. Hirohashi,et al.  Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[35]  M. Ferguson-Smith,et al.  Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. , 1994, Human molecular genetics.

[36]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[38]  D. Sidransky,et al.  Urological Survey UROLOGICAL ONCOLOGY: RENAL, URETERAL AND RETROPERITONEAL TUMORS Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients With Renal Cancer , 2005 .

[39]  S. Clifford,et al.  Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. , 1998, Genes, chromosomes & cancer.

[40]  GASTROENTEROLOGY 2006;131:797–808 BASIC–ALIMENTARY TRACT A Genome-Wide Search Identifies Epigenetic Silencing of Somatostatin, , 2022 .